MANNKIND CORP Foreign Currency Transaction Loss, before Tax
MANNKIND CORP (MNKD) reported Foreign Currency Transaction Loss, before Tax of $3.04 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2016-11-09
- MANNKIND CORP foreign currency transaction loss, before tax for the quarter ending 2016-09-30 was $1.01M.
- MANNKIND CORP foreign currency transaction loss, before tax for the quarter ending 2016-06-30 was $2.40M.
- MANNKIND CORP foreign currency transaction loss, before tax for the quarter ending 2016-03-31 was $2.36M.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month |
|---|---|---|---|
| 2016-09-30 | $1.01M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $3.41M derived: sum of 2 quarters · filed 2016-11-09 | $3.04M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.40M 10-Q/A · filed 2016-08-10 | $2.02M 10-Q/A · filed 2016-08-10 | |
| 2016-03-31 | $2.36M 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |